Ensoma, Inc.
Biotechnology company · Boston, Massachusetts, United States
Ensoma, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $129 million sold in a notice filed in 2023.
Ensoma at a glance
What does Ensoma do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $129 million sold (2023).
Frequently asked questions about Ensoma
Where is Ensoma headquartered?
Ensoma, Inc. is headquartered in Boston, Massachusetts, United States.
What does Ensoma do?
Ensoma, Inc. is a biotechnology company.
When was Ensoma founded?
The earliest incorporation on record for Ensoma, Inc. is in 2019, according to public company registers.
Similar companies
- Syntis Bio, Inc.Boston, Massachusetts, United States
- Strand Therapeutics Inc.Boston, Massachusetts, United States
- Pear Therapeutics, Inc.Boston, Massachusetts, United States
- Aura Biosciences, Inc.Boston, Massachusetts, United States
- Holobiome, Inc.Boston, Massachusetts, United States
- Leuko Labs, Inc.Boston, Massachusetts, United States
- Compass Therapeutics, Inc.Boston, Massachusetts, United States
- Odyssey Therapeutics, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences